Ardelyx Says Japan Approves Tenapanor For Hyperphosphatemia

RTTNews | 686天前
Ardelyx Says Japan Approves Tenapanor For Hyperphosphatemia

(RTTNews) - Biopharmaceutical company Ardelyx, Inc. (ARDX) announced Monday that its collaboration partner in Japan, Kyowa Kirin Co., Ltd., has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the New Drug Application (NDA) for tenapanor for the improvement of hyperphosphatemia in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor will be marketed with the brand name PHOZEVEL in Japan.

This approval triggers an aggregate of $30 million from Kyowa Kirin to Ardelyx in milestone payments and payments under the recent amendment to the license agreement between Ardelyx and Kyowa Kirin.

As a result of this approval, Ardelyx will also receive a $5 million payment under the terms of its agreement with HealthCare Royalty Partners. In addition, Ardelyx may also receive an additional $5 million from Healthcare Royalty Partners in the event net sales in Japan exceed a certain target by 2025.

The NDA in Japan was supported by data from four Phase 3 clinical trials, conducted in Japan by Kyowa Kirin in patients with hyperphosphatemia on maintenance dialysis.

Across Kyowa Kirin's clinical program, tenapanor demonstrated statistically significant reductions in serum phosphorus levels, both as monotherapy and when added to phosphate binders, for patients whose serum phosphorus levels were poorly controlled on phosphate binders alone.

read more
Ardelyx To Receive Up To $20 Mln Financing Deal With HealthCare Royalty Partners

Ardelyx To Receive Up To $20 Mln Financing Deal With HealthCare Royalty Partners

Biopharmaceutical company Ardelyx, Inc. (ARDX) announced Thursday that the company may receive up to $20 million from HealthCare Royalty Partners from the sale of its future royalties and sales milestones from Kyowa Kirin Co., Ltd., its collaboration partner in Japan for the commercialization of tenapanor for hyperphosphatemia.
RTTNews | 1138天前
Rate Cut Hopes Drag The Dollar Down

Rate Cut Hopes Drag The Dollar Down

The U.S. dollar declined against major currencies during the week ended August 8 amidst weak economic data that renewed hopes of a larger-than expected and higher-than-expected monetary policy easing by the Federal Reserve.
RTTNews | 38分鐘前
Bay Street Likely To Open Slightly Higher, But Weak Metal Prices Could Weigh

Bay Street Likely To Open Slightly Higher, But Weak Metal Prices Could Weigh

Canadian stocks may open with a slightly positive bias on Monday with investors looking ahead to the crucial U.S. inflation data due this week. The focus is also Trump administration's trade negotiations with China, and on the upcoming talks between the U.S. and Russia, aimed at bringing an end to the war in Ukraine.
RTTNews | 2小時51分鐘前
FTSE 100 Up Marginally As Investors Look For Direction

FTSE 100 Up Marginally As Investors Look For Direction

The U.K. market is up in positive territory a little before noon on Monday with select counters attracting some strong buying interest. Uncertainty on the tariff front is rendering the mood a bit cautious and limiting the market's upside.
RTTNews | 4小時26分鐘前
CAC 40 Drifts Lower In Lackluster Trade

CAC 40 Drifts Lower In Lackluster Trade

French stocks are down in negative territory on Monday as investors look for direction and make cautious moves while awaiting U.S. - Russia talks set to take place later in the week.
RTTNews | 4小時46分鐘前
UK Job Placements Decline Sharply On Weaker Confidence & Budget Pressures

UK Job Placements Decline Sharply On Weaker Confidence & Budget Pressures

UK job placements logged a steep decline in July due to weaker confidence around the economic outlook and rising employment costs, monthly data from S&P Global showed Monday. Permanent staff appointments declined sharply in July and temp billings registered its biggest fall in five months, the KPMG/REC Report on Jobs said.
RTTNews | 5小時46分鐘前